Multifunctional Redox Modulators Protect Auditory, Visual, and Cognitive Function.

Area of Science:

• Neuroscience
• Ophthalmology
• Otolaryngology
• Biochemistry

Background:

• Oxidative stress, characterized by reactive oxygen species (ROS), metal dyshomeostasis, and mitochondrial dysfunction, is a key factor in vision, hearing, and neurodegenerative diseases.
• Current treatments are insufficient, highlighting the need for novel therapeutic strategies to prevent these debilitating conditions.

Purpose of the Study:

• To discuss the role of oxidative stress and metal dyshomeostasis in sensory and neural degeneration.
• To explore the potential benefits of multifunctional redox modulators (MFRMs) in suppressing these degenerative processes.

Main Methods:

• MFRMs were investigated for their ability to reduce free radicals and bind transition metals implicated in ROS generation.
• The study examined MFRM capacity to redistribute zinc from amyloid-beta (Aβ) complexes and protect mitochondria.
• In vivo studies assessed the efficacy of oral MFRM administration in various models of degeneration.

Main Results:

• MFRMs effectively reduce ROS and bind transition metals (copper, iron, zinc, manganese) without depleting cytoplasmic zinc.
• Oral MFRM administration prevented ROS-induced cataracts, light-induced retinal degeneration, Aβ plaque formation, and noise-induced hearing loss.
• MFRMs protected auditory hair cells and mitochondria from manganese-induced dysfunction.

Conclusions:

• Multifunctional redox modulators (MFRMs) represent a promising new class of therapeutic agents for preventing sensory and neural degeneration.
• Further research, including pharmacokinetic, pharmacodynamic, and toxicological studies, is required for clinical translation and widespread use.